Literature DB >> 16789007

Distinct changing profiles of hepatitis A and E virus infection among patients with acute hepatitis, patients on maintenance hemodialysis and healthy individuals in Japan.

Takehiro Mitsui1, Yukie Tsukamoto, Akinori Hirose, Shigeru Suzuki, Chikao Yamazaki, Kazuo Masuko, Fumio Tsuda, Kazunori Endo, Masaharu Takahashi, Hiroaki Okamoto.   

Abstract

To compare the epidemiologic profiles of hepatitis A virus (HAV) and hepatitis E virus (HEV) infections in Japan, the prevalence of clinical or subclinical HAV and HEV infections was investigated serologically and molecularly among 128 consecutive patients (age, mean +/- standard deviation, 37.5 +/- 14.7 years) who contracted acute hepatitis between 1989 and 2005 in a city hospital, and among 416 hemodialysis patients (60.1 +/- 12.6 years) and 266 medical staff members (34.6 +/- 11.4 years) at the same hospital, using stored periodic serum samples collected since the start of hemodialysis or employment, respectively. Between 1989 and 1995, among 93 patients with acute hepatitis, 51 (54.8%) were diagnosed with hepatitis A and only one patient with hepatitis E. Between 1996 and 2005, however, among 35 patients, only 3 (8.6%) were diagnosed with hepatitis A and 2 (5.7%) with hepatitis E. Although subclinical HEV infection was recognized in four hemodialysis patients (one each in 1979, 1980, 1988, and 2003) and two medical staff members (1978 and 2003) in previous studies, none of the 191 hemodialysis patients who had been negative for anti-HAV at the start of hemodialysis contracted HAV infection during the observation period of 7.6 +/- 6.4 years. Only one (0.4%) of the 246 medical staff members who had been negative for anti-HAV at the start of employment acquired hepatitis A during the observation period of 7.9 +/- 8.0 years: none had subclinical HAV infection. Clinical or subclinical HEV infection has occurred rarely during the last three decades, while HAV infection has markedly decreased at least since 1996. 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16789007     DOI: 10.1002/jmv.20657

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  14 in total

1.  Clopidogrel, Turkey and a red herring?

Authors:  S P Leighton; C Gordon; A Shand
Journal:  BMJ Case Rep       Date:  2011-04-09

Review 2.  Hepatitis E virus infection.

Authors:  Nassim Kamar; Harry R Dalton; Florence Abravanel; Jacques Izopet
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

Review 3.  Hepatitis E virus in the countries of the Middle East and North Africa region: an awareness of an infectious threat to blood safety.

Authors:  Soha Yazbek; Khalil Kreidieh; Sami Ramia
Journal:  Infection       Date:  2015-06-26       Impact factor: 3.553

4.  Hepatitis E in hemodialysis and kidney transplant patients in south-east Italy.

Authors:  Gaetano Scotto; Filippo Aucella; Giuseppe Grandaliano; Domenico Martinelli; Mario Querques; Antonio Gesuete; Barbara Infante; Paolo Delli Carri; Salvatore Massa; Giovanna Salatino; Fabio Bulla; Vincenzina Fazio
Journal:  World J Gastroenterol       Date:  2015-03-21       Impact factor: 5.742

5.  The Enigma of Hepatitis E Virus.

Authors:  Liza Bronner Murrison; Kenneth E Sherman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-08

6.  Autochthonous hepatitis E in Southwest England: a comparison with hepatitis A.

Authors:  H R Dalton; W Stableforth; S Hazeldine; P Thurairajah; R Ramnarace; U Warshow; S Ijaz; V Ellis; R Bendall
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-02-26       Impact factor: 3.267

7.  Epidemiology, diagnosis, vaccines, and bibliometric analysis of the 100 top-cited studies on Hepatitis E virus.

Authors:  Tauseef Ahmad; Saima Nasir; Taha Hussein Musa; Saif Aldeen S AlRyalat; Muhammad Khan; Jin Hui
Journal:  Hum Vaccin Immunother       Date:  2020-08-05       Impact factor: 3.452

8.  Acute infection by hepatitis E virus with a slight immunoglobulin M antibody response.

Authors:  Yuki Inagaki; Yukio Oshiro; Mamiko Imanishi; Kazunori Ishige; Masaharu Takahashi; Hiroaki Okamoto; Nobuhiro Ohkohchi
Journal:  Clin J Gastroenterol       Date:  2015-07-28

9.  Full-length genomic sequence of subgenotype IIIA hepatitis A virus isolate in Republic of Korea.

Authors:  Ah-Ra Lee; Sung-Geun Lee; Lae-Hyung Kang; Weon-Hwa Jheong; Soon-Young Paik
Journal:  Biomed Res Int       Date:  2013-08-07       Impact factor: 3.411

10.  Hepatitis e virus detection in liver tissue from patients with suspected drug-induced liver injury.

Authors:  Obinna Chijioke; Marion Bawohl; Erik Springer; Achim Weber
Journal:  Front Med (Lausanne)       Date:  2015-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.